In this guide, NORML highlights various online tools to assist reformers in their advocacy endeavors. As America awaits a return to normal, here are numerous steps that you can take today to keep successfully engaged with pundits, politicians, and other influencers during this pandemic.
By completing this survey, you will help NORML better understand how to most effectively represent your interests in our lobbying, organizing, and educational efforts.
Activists have been working for months registering new voters, collecting signatures, and educating the public, in hopes of giving voters in their state the opportunity to make their voices heard and cast their vote for marijuana. But social distancing guidelines have made this work virtually impossible. Here is an overview of key 2020 ballot initiative efforts and where they stand now.
Ten members of the Senate, led by Senators Jacky Rosen (D-NV) and Ron Wyden (D-OR), and 34 members of the House, led by Representatives Earl Blumenauer (D-OR) and Tom McClintock (R-CA), have recently issued letters requesting Small Business Administration funding programs be expanded so that they may be accessed by state-licensed cannabis businesses.
NORML encourages those who wish to express their support for marijuana policy reform this 4/20 to engage in the many online/virtual celebrations taking place throughout the day.
Here’s a state-by-state list of jurisdictions that designate medical cannabis outlets as essential businesses during COVID-19, and which are allowed to provide other options such as curbside pickup, delivery, and virtual doctors visits.
Here at NORML, we take our work seriously. With so many unsubstantiated claims being made regarding cannabis and staying safe during the COVID-19 outbreak, we’ve compiled a list of resources for consumers and ways your activism can thrive during social distancing.
Investigators are seeking respondents to participate in an anonymous electronic survey to evaluate whether consumers have experienced changes in their frequency of cannabis use, dosing, access, or preferred methods of ingestion as a result of either COVID-19-related closures or emergency actions.